Home
>
National Drug Code (NDC)
>
Orphenadrine Citrate
Orphenadrine Citrate - 0591-3222-47 - (Orphenadrine Citrate)
Drug Information of Orphenadrine Citrate
| Product NDC: | 0591-3222 |
| Proprietary Name: | Orphenadrine Citrate |
| Non Proprietary Name: | Orphenadrine Citrate |
| Active Ingredient(s): | 30 mg/mL & nbsp; Orphenadrine Citrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Orphenadrine Citrate
| Product NDC: | 0591-3222 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084779 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100708 |
Package Information of Orphenadrine Citrate
| Package NDC: | 0591-3222-47 |
| Package Description: | 10 AMPULE in 1 CARTON (0591-3222-47) > 2 mL in 1 AMPULE (0591-3222-02) |
NDC Information of Orphenadrine Citrate
| NDC Code | 0591-3222-47 |
| Proprietary Name | Orphenadrine Citrate |
| Package Description | 10 AMPULE in 1 CARTON (0591-3222-47) > 2 mL in 1 AMPULE (0591-3222-02) |
| Product NDC | 0591-3222 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Orphenadrine Citrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100708 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 30 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |
